However, overexpression of GPAA1 dramatically promoted tumour growth and Akt activation, which were reversed by trastuzumab treatment (Fig. 5e, f, g and h), indicating the diagnostic and therapeutic potential of GPAA1 in gastric cancer. The gene discussed is AKT1; the disease is gastric cancer.